Serotype-independent protection against invasive pneumococcal infections conferred by live vaccine with LGT deletion

A. Yeung Jang, Ki Bum Ahn, Yong Zhi, Hyun Jung Ji, Jing Zhang, Seung Hyun Han, Huichen Guo, Sangyong Lim, Joon-Young Song, Jae Hyang Lim, Ho Seong Seo

Research output: Contribution to journalArticle

Abstract

Streptococcus pneumoniae is the most common respiratory bacterial pathogen among cases of community-acquired infection in young children, older adults, and individuals with underlying medical conditions. Although capsular polysaccharide-based pneumococcal vaccines have contributed to significant decrease in invasive pneumococcal infections, these vaccines have some limitations, including limited serotype coverage, lack of effective mucosal antibody responses, and high costs. In this study, we investigated the safety and immunogenicity of a live, whole-cell pneumococcal vaccine constructed by deleting the gene for prolipoprotein diacylglyceryl transferase (lgt) from the encapsulated pneumococcal strain TIGR4 (TIGR4Δlgt) for protection against heterologous pneumococcal strains. Pneumococcal strain TIGR4 was successfully attenuated by deletion of lgt, resulting in the loss of inflammatory activity and virulence. TIGR4Δlgt colonized the nasopharynx long enough to induce strong mucosal IgA and IgG2b-dominant systemic antibody responses that were cross-reactive to heterologous pneumococcal serotypes. Finally, intranasal immunization with TIGR4Δlgt provided serotype-independent protection against pneumococcal challenge in mice. Taken together, our results suggest that TIGR4Δlgt is an avirulent and attractive broad-spectrum pneumococcal vaccine candidate. More broadly, we assert that modulation of such “master” metabolic genes represents an emerging strategy for developing more effective vaccines against numerous infectious agents.

Original languageEnglish
Article number1212
JournalFrontiers in immunology
Volume10
Issue numberMAY
DOIs
Publication statusPublished - 2019 Jan 1

Fingerprint

Pneumococcal Infections
Pneumococcal Vaccines
Vaccines
Antibody Formation
Community-Acquired Infections
Nasopharynx
Streptococcus pneumoniae
Immunoglobulin A
Genes
Virulence
Immunization
Safety
Costs and Cost Analysis
Serogroup

Keywords

  • Lgt
  • Lipoprotein
  • Live attenuated vaccine
  • Mucosal immunity
  • Streptococcus pneumoniae

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Serotype-independent protection against invasive pneumococcal infections conferred by live vaccine with LGT deletion. / Jang, A. Yeung; Ahn, Ki Bum; Zhi, Yong; Ji, Hyun Jung; Zhang, Jing; Han, Seung Hyun; Guo, Huichen; Lim, Sangyong; Song, Joon-Young; Lim, Jae Hyang; Seo, Ho Seong.

In: Frontiers in immunology, Vol. 10, No. MAY, 1212, 01.01.2019.

Research output: Contribution to journalArticle

Jang, A. Yeung ; Ahn, Ki Bum ; Zhi, Yong ; Ji, Hyun Jung ; Zhang, Jing ; Han, Seung Hyun ; Guo, Huichen ; Lim, Sangyong ; Song, Joon-Young ; Lim, Jae Hyang ; Seo, Ho Seong. / Serotype-independent protection against invasive pneumococcal infections conferred by live vaccine with LGT deletion. In: Frontiers in immunology. 2019 ; Vol. 10, No. MAY.
@article{713709cb69694befb61ea94bbff3edc4,
title = "Serotype-independent protection against invasive pneumococcal infections conferred by live vaccine with LGT deletion",
abstract = "Streptococcus pneumoniae is the most common respiratory bacterial pathogen among cases of community-acquired infection in young children, older adults, and individuals with underlying medical conditions. Although capsular polysaccharide-based pneumococcal vaccines have contributed to significant decrease in invasive pneumococcal infections, these vaccines have some limitations, including limited serotype coverage, lack of effective mucosal antibody responses, and high costs. In this study, we investigated the safety and immunogenicity of a live, whole-cell pneumococcal vaccine constructed by deleting the gene for prolipoprotein diacylglyceryl transferase (lgt) from the encapsulated pneumococcal strain TIGR4 (TIGR4Δlgt) for protection against heterologous pneumococcal strains. Pneumococcal strain TIGR4 was successfully attenuated by deletion of lgt, resulting in the loss of inflammatory activity and virulence. TIGR4Δlgt colonized the nasopharynx long enough to induce strong mucosal IgA and IgG2b-dominant systemic antibody responses that were cross-reactive to heterologous pneumococcal serotypes. Finally, intranasal immunization with TIGR4Δlgt provided serotype-independent protection against pneumococcal challenge in mice. Taken together, our results suggest that TIGR4Δlgt is an avirulent and attractive broad-spectrum pneumococcal vaccine candidate. More broadly, we assert that modulation of such “master” metabolic genes represents an emerging strategy for developing more effective vaccines against numerous infectious agents.",
keywords = "Lgt, Lipoprotein, Live attenuated vaccine, Mucosal immunity, Streptococcus pneumoniae",
author = "Jang, {A. Yeung} and Ahn, {Ki Bum} and Yong Zhi and Ji, {Hyun Jung} and Jing Zhang and Han, {Seung Hyun} and Huichen Guo and Sangyong Lim and Joon-Young Song and Lim, {Jae Hyang} and Seo, {Ho Seong}",
year = "2019",
month = "1",
day = "1",
doi = "10.3389/fimmu.2019.01212",
language = "English",
volume = "10",
journal = "Frontiers in Immunology",
issn = "1664-3224",
publisher = "Frontiers Media S. A.",
number = "MAY",

}

TY - JOUR

T1 - Serotype-independent protection against invasive pneumococcal infections conferred by live vaccine with LGT deletion

AU - Jang, A. Yeung

AU - Ahn, Ki Bum

AU - Zhi, Yong

AU - Ji, Hyun Jung

AU - Zhang, Jing

AU - Han, Seung Hyun

AU - Guo, Huichen

AU - Lim, Sangyong

AU - Song, Joon-Young

AU - Lim, Jae Hyang

AU - Seo, Ho Seong

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Streptococcus pneumoniae is the most common respiratory bacterial pathogen among cases of community-acquired infection in young children, older adults, and individuals with underlying medical conditions. Although capsular polysaccharide-based pneumococcal vaccines have contributed to significant decrease in invasive pneumococcal infections, these vaccines have some limitations, including limited serotype coverage, lack of effective mucosal antibody responses, and high costs. In this study, we investigated the safety and immunogenicity of a live, whole-cell pneumococcal vaccine constructed by deleting the gene for prolipoprotein diacylglyceryl transferase (lgt) from the encapsulated pneumococcal strain TIGR4 (TIGR4Δlgt) for protection against heterologous pneumococcal strains. Pneumococcal strain TIGR4 was successfully attenuated by deletion of lgt, resulting in the loss of inflammatory activity and virulence. TIGR4Δlgt colonized the nasopharynx long enough to induce strong mucosal IgA and IgG2b-dominant systemic antibody responses that were cross-reactive to heterologous pneumococcal serotypes. Finally, intranasal immunization with TIGR4Δlgt provided serotype-independent protection against pneumococcal challenge in mice. Taken together, our results suggest that TIGR4Δlgt is an avirulent and attractive broad-spectrum pneumococcal vaccine candidate. More broadly, we assert that modulation of such “master” metabolic genes represents an emerging strategy for developing more effective vaccines against numerous infectious agents.

AB - Streptococcus pneumoniae is the most common respiratory bacterial pathogen among cases of community-acquired infection in young children, older adults, and individuals with underlying medical conditions. Although capsular polysaccharide-based pneumococcal vaccines have contributed to significant decrease in invasive pneumococcal infections, these vaccines have some limitations, including limited serotype coverage, lack of effective mucosal antibody responses, and high costs. In this study, we investigated the safety and immunogenicity of a live, whole-cell pneumococcal vaccine constructed by deleting the gene for prolipoprotein diacylglyceryl transferase (lgt) from the encapsulated pneumococcal strain TIGR4 (TIGR4Δlgt) for protection against heterologous pneumococcal strains. Pneumococcal strain TIGR4 was successfully attenuated by deletion of lgt, resulting in the loss of inflammatory activity and virulence. TIGR4Δlgt colonized the nasopharynx long enough to induce strong mucosal IgA and IgG2b-dominant systemic antibody responses that were cross-reactive to heterologous pneumococcal serotypes. Finally, intranasal immunization with TIGR4Δlgt provided serotype-independent protection against pneumococcal challenge in mice. Taken together, our results suggest that TIGR4Δlgt is an avirulent and attractive broad-spectrum pneumococcal vaccine candidate. More broadly, we assert that modulation of such “master” metabolic genes represents an emerging strategy for developing more effective vaccines against numerous infectious agents.

KW - Lgt

KW - Lipoprotein

KW - Live attenuated vaccine

KW - Mucosal immunity

KW - Streptococcus pneumoniae

UR - http://www.scopus.com/inward/record.url?scp=85068104370&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068104370&partnerID=8YFLogxK

U2 - 10.3389/fimmu.2019.01212

DO - 10.3389/fimmu.2019.01212

M3 - Article

C2 - 31191555

AN - SCOPUS:85068104370

VL - 10

JO - Frontiers in Immunology

JF - Frontiers in Immunology

SN - 1664-3224

IS - MAY

M1 - 1212

ER -